We have characterized the mechanical compliance of an improved version of the suspension system used to position the electrode-bearing membrane of an intradural neuromodulator on the dorsal pial surface of the spinal cord. Over the compression span of 5 mm, it exhibited a restoring force of 2.4 lN lm À1 and a mean pressure of 0.5 mm Hg (¼66 Pa) on the surface below it, well within the range of normal intrathecal pressures. We have implanted prototype devices employing this suspension and a novel device fixation technique in a chronic ovine model of spinal cord stimulation and found that it maintains stable contact at the electrode-pia interface without lead fracture, as determined by measurement of the inter-contact impedances. V C 2013 AIP Publishing LLC.
I. INTRODUCTION
We are developing the Human Spinal Cord Modulation System (HSCMS) as an improved means of treating intractable back and leg pain via selective neuromodulation of nerve fibers within the dorsal columns. [1] [2] [3] In a substantial departure from the existing epidural approaches to spinal cord stimulation, the HSCMS will be positioned intradurally, with the electrode-bearing membrane of the device in direct contact with the pial surface of the spinal cord. From a historical perspective, our approach is partly a reprise of how spinal cord stimulators were first implanted in patients. 4, 5 However, technical issues associated with the procedures and devices available at the time caused the intradural approach to be abandoned by the mid-1970s in favor of epidural placement of the stimulation leads. 6 This change in surgical paradigm was not without its trade-offs: while epidural positioning of the leads did not require durotomy which sometimes led to cerebrospinal fluid (CSF) leakage, it did mean that the electrical currents produced by the stimuli were subject to shunting by the relatively high conductivity CSF. 7 That effect, along with concerns over lead breakage and positional stability, has made it difficult for epidural devices to achieve targeted stimulation of specific spinal cord fibers without painful excitation of non-targeted structures, such as the dorsal nerve rootlets. This suboptimal stimulus delivery capability contributes to the limited therapeutic efficacy of current devices in up to half of all patients who have received epidural spinal cord stimulators. 8 The HSCMS, a prototype of which is shown in Fig. 1 , seeks to overcome these difficulties by stabilizing the position of a soft electrode-bearing membrane directly on the spinal cord, which is mobile within the spinal canal, thus enabling more precise and efficacious stimulation of the targeted fibers. 2, 9 This is accomplished by exposing the dorsal surface of the spinal cord via laminectomy and durotomy, carefully positioning the HSCMS membrane onto the spinal cord, closing the thecal sac by re-approximating the dura mater over a dural cuff (with the electrode leads in a looped configuration underneath it) and then using a titanium strap and hardware to bridge the laminectomy and anchor the upper end of the HSCMS assembly securely in place, as shown schematically in Fig. 2 . The dural cuff provides a water-tight seal that prevents CSF leakage and serves as the entry point for the leads that are connected to the electrode array in the membrane on the spinal cord below it. The titanium bridge (termed the Oya strap 10 ), the dural cuff components, and the intradural lead loops form a suspension system the primary design goal of which is to keep the electrode-bearing membrane in gentle and stable contact with the pial surface of the spinal cord. It is also important that the suspension system be designed to minimize the risk of fracturing either the individual lead segments beneath the dura or the bundled assembly of them which extends from the outer surface of the dura to the subcutaneous pulse generator that produces the stimulus signals.
Our purpose here is to report the results of a series of in vitro and in vivo experiments that were aimed at exploring the performance characteristics of the HSCMS suspension system's key components. We begin by describing an improved version of the compliant lead-loop assembly that controls the dynamics of the membrane's interaction with the spinal cord. We then go on to examine how the prototype device, including the extradural components of the suspension system, performs in a chronic ovine model of HSCMS implantation. In particular, we assess the long term mechanical patency and positional stability of the leads in vivo via radiographic imaging and measurement of the impedance values at the electrode-spinal cord interface. We close by discussing the implications of these findings in terms of design improvements for the HSCMS and its possible application in a pilot trial in patients suffering from refractory back and leg pain.
II. SUSPENSION SYSTEM DYNAMICS

A. Design requirements
In its original conception, 1, 11 the HSCMS was to be a wirelessly coupled device positioned on the pial surface of the spinal cord and held in place there by soft, pre-formed polymeric arms that conformed to the cord's circumferential shape. The feasibility of a wireless emitter/receiver system sized to the human spinal canal, able to convey suitable frequency modulated control signals, and having adequate energy in the carrier wave to power the receiver was then demonstrated, 12 and this approach remains a reasonable and interesting long-term goal for future deployment. However, in order to accelerate the device development cycle, we have chosen to pursue the wired version of the HSCMS in the near term, and a number of intradural fixation/suspension methods were conceived and tested for it en route to the present version. All of them were predicated on the need for a slender geometric profile for the device, including its leads to insure uninterrupted flow of CSF (and thus minimize the risk of inflammation or syrinx development) at the implantation site. In terms of the suspension system dynamics, there are two important requirements that must be met. First, the electrode-bearing membrane of the device must make continuous contact with the spinal cord in such a way that the pial blood vessels are not damaged so that there is no hematoma formation. Second, the suspension system must be able to accommodate the normal physiologic motions of the spinal cord, which can move within the thecal sac by up to one cm or more in the rostral-caudal (R/C, i.e., axial) direction and up to several mm in the anterior-posterior (A/P) and lateral directions during flexion, extension, and twisting of the spine. 13, 14 The coupling point between these requirements is the need for continuous and benign contact between the electrode membrane and the pial surface.
In our first round of pre-clinical studies, 15, 16 we compared a circumferential fixation technique ("dorsal arc clamping") against an alternative approach in which the device's thin polymeric arms were instead attached to surrogate denticulate ligaments in an in vivo ovine model. From a mechanical perspective, the advantage of the dorsal arc clamping method was that there was no risk of lead migration relative to the spinal cord surface. On the other hand, the denticulate ligament approach offered the possibility of using the body's natural suspension system for the spinal cord itself to lightly couple the device to the pial surface. However, the results of that study 15 showed that the dorsal arc clamping method led to an unavoidable residual level of spinal cord compression and that the dentate ligament fixation method, while workable, would be technically challenging to implement as part of a routine surgical procedure. Both of these findings pointed the way towards the concept embodied in Figs. 1 and 2, in which the intradural lead assembly could be designed to have a compliance which provided just enough restoring force to keep the electrode membrane in appropriate contact with the pial surface as the spinal cord moves in response to patient postural changes.
B. Coupling strengths
The central feature of this design is the loop-shaped configuration of the subdural segments of the leads. In the prototype device, there are six electrodes with one lead each. The leads, made of 35N LT V R silver-core cables, are approximately 0.1 mm in diameter (including insulation) and maintain a C-shaped arc over their length due to pre-forming on the mandrel on which the device is assembled, and the entry and exit angles at their termination points. With three of the leads extending from the electrode-bearing surface in the rostral direction of the device and the other three caudally, the result is the roughly circular loop structure for the uncompressed lead assembly shown in Fig. 1 (This   FIG. 2. Schematic illustration of the lead bundle passing through the durotomy seal and being anchored by the titanium mesh Oya strap that bridges the laminectomy gap, thus providing strain relief for the lead bundle and reducing the risk of fatigue and fracture of the wires. In early versions of the device, the lead loops were oriented transversely to the longitudinal axis of the spinal cord as shown here and in Fig. 5 . In the most recent versions, they are oriented longitudinally as in Fig. 1 .
description of the device is given from a technical perspective. In terms of the nomenclature adopted by clinical practitioners, the electrode bearing surface and lead-loop assemblies would be referred to collectively as a six electrode modified paddle lead with a single extension cable). Because there are large variations between patients in spinal cord morphology 17 and in the ranges of spinal cord movement within the thecal sac, 13, 14 we have had different sizes of the prototype made, with uncompressed lead-loop diameters of 6-12 mm. In a recent set of compression measurements made on a device with a 6.5 mm diameter lead loop, 18 we used a precision differential force-gauge system (based on an Ametek model SLC-250G load cell and a Denver Instruments model TR-403 digital scale 18 ) to determine that it had a compliance of %63 lN lm À1 . The corresponding pressure exerted by its 50 mm 2 electrode-bearing surface on an anthropomorphic silicone model of the spinal cord [19] [20] [21] had a mid-span value of %14.1 mm Hg (¼1.88 Â 10 3 Pa) over the 3 mm range of compression. This degree of loop compression corresponds to the typical thickness of the CSF layer in the mid-thoracic region, and the resulting mid-span pressure lies reassuringly within the range of normal intrathecal pressures in humans.
Since the bending moment for a circular C-shaped spring will decrease as its radius of curvature increases, 22 the larger diameter devices would be expected to have an even softer footprint on the spinal cord. Using the same instrumentation and method, 18 we have now measured the restoring force as a function of compression for a device with a lead-loop mean diameter of %12 mm and having an electrode-bearing surface area of %112 mm 2 . The resulting data (covering a larger compression range than in our earlier study) are shown in Fig. 3(a) , which reveal that its compliance, given by the slope of the linear fit (R 2 ¼ 0.994), is %2.4 lN lm
À1
, is about 26 times softer than the 6 mm diameter device. The pressure it applied to the anthropomorphic spinal cord surrogate, plotted in Fig. 3(b) , is correspondingly lower than that of the small diameter device: the mid-span value in this case was roughly 0.5 mm Hg (¼66 Pa), well below the ambient intrathecal pressure. As an additional point of comparison, we note that Reid 23 measured the forces needed to displace the spinal cord anteriorly within the thoracic region, over ranges of up to 3 mm. From that data (his Table III , "normal posture" results), the equivalent compliance (due primarily to the dentate ligaments) was, on average over three cases, %231 lN lm À1 , roughly a factor of 10 2 stiffer than that found for our 12 mm lead-loop device. While this suggests that there should be very little displacement of the spinal cord in the A/P direction due to the force normal to the pial surface produced by HSCMS, it is important to note that Reid's data were taken in cadaver spines, and the fixation process might have increased the stiffness somewhat relative to that of in vivo tissues. Therefore, this point will be tested in future acute in vivo studies, by making direct observations of the cord's anterior displacement as a function of the HSCMS compression force. Ultimately, at the point of human pilot trials, MR-based or myelographic assessment of the spinal cord's response to the HSCMS will be incorporated as needed into the protocols for confirmation of safety.
Our results generally agree with the predicted behavior of C-shaped springs found in the literature. 22, 24, 25 Even though the displacements of such springs in response to applied bending moments can only be modeled precisely via either elliptical functions 22 or homotopy methods, 24 the load vs. deflection curves for weak springs are expected to be very nearly linear at mid-range, 22 and this behavior was confirmed in our findings (see Fig. 3(a) here, and Fig. 3 in Oliynik et al.
18
).
C. Fixation technique
It is important to provide an in situ, spinal anchoring point for the suspension system in order to help stabilize the position of the proximal end of the lead loops. This minimizes the risks of fatiguing the very small diameter wires or otherwise weakening them in ways that might change the dynamics of the suspension system or lead to mechanical or electrical failure of the implant. Toward this end, as shown in Fig. 2 , an Oya strap bridging device is used to span the laminectomy gap. It is a thin (0.2 mm thick), stiff, titaniummesh plate nominally 35 mm long by 6 mm wide, which can be shortened intra-operatively to match the exact width of the laminectomy gap before its ends are screwed in place into the vertebral walls. Figure 4 is an edge-on, close-up photograph of this device, showing the polymeric conduit installed at its midline, inside of which the lead bundle that exits the dural cuff is secured, thus providing the stress relief needed to stabilize the compliance of the soft-coupled suspension system. Titanium structures of this scale have long been used routinely in neurosurgical procedures for vertebral bone repair and craniectomy closure, and their biomechanical performance is well understood. [26] [27] [28] Hasegawa et al. 27 in particular have made dynamic compression measurements of the stiffness at the titanium-bone interface and found it to be on the order of 0.5 kN mm À1 ¼ 5 Â 10 5 lN lm
À1
. Their result is >10 5 times the measured compliance of our 12 mm diameter HSCMS device, leading to good mechanical stability at the proximal end of the suspension system.
III. SUSPENSION SYSTEM PERFORMANCE: RESULTS AND DISCUSSION
A. Testing methodology
Our original in vivo trials, discussed above, were all acute studies aimed at exploring device implantation methods 15, 16 and comparing epidural vs. intradural stimulation strategies. 2, 3 We now have underway a series of chronic in vivo ovine studies in which the goals are to (1) use gait analysis 29, 30 to evaluate the efficacy of subdural spinal cord stimulation in a large animal model, (2) carry out histological assessments of the spinal cord tissue at the end of the study to assess the long-term safety of HSCMS implantation, and (3) test the ability of the HSCMS suspension system to maintain stable contact between the implant's electrodes and the pial surface of the spinal cord. The first two arms of this study are still underway, and the final results from that work will be reported upon completion. However, preliminary data from an intermediate time point in the third arm of the study have now been taken and are presented below.
The anesthetic and surgical protocols for the six adult sheep involved in these institutionally approved, chronic in vivo investigations are published elsewhere. 2, 3 One control animal received no HSCMS implant. The details of the types of devices that were implanted in the other five animals in this cohort are shown in Table I . The purpose here was to investigate the performance of two substantially different types of device and fixation methods. That used in animal no. 1 served retrospectively as a control device as it was intentionally very similar in form to the devices used in our acute in vivo studies of dentate ligament fixation, which had been carried out earlier. 15 As shown in Fig. 5 , its electrodebearing surface was a pliable thin film of silicone with the 0.1 mm diameter, insulated, single-strand leads of MP35N wire fixed to the upper side of that surface and then extending from the ends of its arms to the exit point in the dura. The lead bundle was then channeled through resorbable Gelfoam V R inserts placed above the dura to fill the void in the vertebral body, with two sutures across the laminectomy gap serving to anchor the lead bundle to the spine.
The HSCMS test devices used in animal nos. 2-5 were constructed as per Fig. 1 . In them, the attachment point for the leads was at the center of the upper surface of the implant, rather than at the ends of its arms as per the device shown in Fig. 5 . In addition to forming the lead-loops for the device's suspension system, the center-body attachment of the leads also minimized the moments that would act to lift the axial ends of the device off the pial surface as the spinal cord moved relative to the lead bundle's exit point in the dura. As mentioned above, the leads for these devices were of 0.1 mm diameter, insulated, multi-strand cables. These devices used the Oya strap for fixation to the vertebral body. An intra-operative view of one of the cases showing this fixation method prior to closure of the durotomy is presented in Fig. 6 . In summary, the control device employed single strand wires that were oriented transversely to the long axis of the spinal cord and incorporated onto the electrode-bearing surface, with the entire device anchored via tensioned sutures across the laminectomy gap. In contrast, the test device employed multi-strand cables in the lead-loop configuration, with fixation via a stiff titanium bridge across the laminectomy gap. Following implantation of their devices per the dates shown in Table I , the animals were put to pasture without restriction on their motions to evaluate the chronic behavior of the suspension systems and fixation methods under realistic biomechanical conditions.
B. Radiographic evaluations
The proximal ends of the lead bundles were externalized at various time points, for the purpose of carrying out the spinal cord stimulation and gait analysis studies. This was performed for animal no. 1 at eight months post-implantation, for animal nos. 2 and 3 at seven months, and for animal nos. 4 and 5 at two months. Radiographs of the implantation region of animal no. 1 are shown in Fig. 7 . The electrode array of the control device is shown in place transversely across the spinal cord in the A/P view of Fig. 7(a) . However, measurements of the inter-electrode impedances (discussed below) across the spinal cord tissues indicated open circuits, thus suggesting that there had been lead breakage, and this was investigated further by inspection of the lateral view of the implantation area shown in Fig. 7(b) . In it, the arrow points to the subcutaneous part of the lead assembly, the circle just above the vertebral body centers on the location where the lead break occurred, and the triangle points toward the electrode-bearing membrane on the spinal cord. Neither the Gelfoam V R nor the suture fixation strands are sufficiently radio-opaque to be visible in either view. In contrast, there was no radiographic or electrical evidence of lead breakage in the test devices (with the possible exception of a single lead in just one of them). Figure 8 shows a representative lateral view of a test device, with the lead bundle clearly fully intact above the vertebral body.
C. Electrophysiological measurements
The stimulation and impedance measurement system used for our spinal cord electrophysiology studies is described in detail elsewhere. 3 The charge-balanced, bi-phasic waveform (amplitude of phase A ¼ 1 V) shown in Fig. 9 was applied to permutations of the electrode pairs in the devices in each animal, and representative data for the measured impedances as a function of stimulation frequency are given in Table II . All four of the test devices were found to function properly, indicating that even in an ovine model where there is very little subdural space and the lead loops are compressed substantially, the suspension system and fixation method were able to keep the electrode-bearing surface of the device in stable contact with the spinal cord and prevent subcutaneous lead breaks. An additional point of interest is that some simple estimates of the charge per phase and the charge density per phase delivered by the prototype HSCMS devices can be made from these data as well, via an elementary volume conductor model. For example, the impedance, Z, was measured to be Z ¼ 3.3 kX at 10 kHz across the central pair of contacts in the HSCMS implanted in animal no. 4. With a phase A current of 303 lA, the total charge transfer during that phase would be (303 lA) Á (25 ls) ¼ 7575 Â 10 À12 C % 7.6 nC. Likewise, at 100 Hz the impedance for that particular electrode pair was 17.1 kX with a phase A total charge transfer of 11.7 nC. The charge density per phase is given by the charge per phase divided by the area of the electrodes, which were 0.7 mm diameter flat discs, hence A ¼ 0.0154 cm 2 . This leads to 7.6 nC/0.0154 cm 2 ¼ 0.49 lC cm À2 phase À1 at 10 kHz and 11.7 nC/0.0154 cm 2 ¼ 0.76 lC cm À2 phase À1 at 100 Hz. These values for the charge per phase and charge density per phase are very small compared with the accepted safety-limit thresholds derived by Shannon. 31 Of course, the peak-to-peak voltage used here was only 1.5 V, hence the small currents flowing into the impedances. Even so, since the power goes as the square of the current, it is instructive to consider the power density per phase in addition to the charge density per phase. In doing so, we find [(303 Â 10 À6 A) 2 Á 3300 X]/0.0154 cm 2 ¼ 19.7 mW cm À2 at 10 kHz and [(58.5 Â 10 À6 A) 2 Á 17100 X]/0.0154 cm 2 ¼ 5.9 mW cm À2 at 100 Hz. So, somewhat counter-intuitively, the charge density is 33% lower at 10 kHz than it is at 100 Hz, but the power density is roughly 300% higher since power goes as the square of the current. These types of analyses may provide some insights into the improved efficacy being reported for high frequency spinal cord stimulation 32 (Precise determinations of all these parameters would clearly require a more realistic electrophysiological model, and we are presently pursuing that goal).
IV. CONCLUSIONS
As discussed in detail above, the two primary design goals for the HSCMS suspension system are to enable the electrode-bearing membrane of the device to make continuous contact with the spinal cord without damaging the spinal cord tissue and to accommodate the normal physiologic motions of the spinal cord during flexion, extension, and twisting of the spine. We have presented here preliminary radiographic and electrophysiological data obtained at intermediate time points during the course of our ongoing in vivo ovine trial which support the conclusion that our prototype device with the "lead-loop" design and titanium bridge fixation method is able to maintain continuous, efficacious contact between the electrode-bearing membrane and the pial surface of the spinal cord. Moreover, our biomechanical measurements of the suspension stiffness have demonstrated that the pressure it applies to an anthropomorphic spinal cord surrogate is well below normal intrathecal pressure inside the spinal canal. This latter point is reassuring in terms of potentially meeting the primary design goal, but full assessment must await histo-pathologic testing of tissue specimens that will be explanted from the animals at the completion of the in vivo trial. It is also encouraging that the Oya strap fixation device kept the proximal subcutaneous portion of the extradural lead bundle free of fractures, thus demonstrating potential for overcoming one of the known limitations of the existing epidural devices: fatigue and breakage of the leads due to positional instabilities of them inside the body. 33 Our future work will focus on completion of the remaining two arms of the ongoing preliminary in vivo study, in preparation for eventual pivotal animal trials needed to apply for an investigational device exemption (IDE) for testing the HSCMS in patients. Among other tasks, the pivotal trials will include efforts aimed at further confirming device stability on the surface of the spinal cord via imaging studies carried out at selected time points over the trial durations, with the body in different orientations relative to gravitational vertical. In parallel with that, we are conducting finite element analyses of the current distributions that can be produced within the target tissues by intradural stimulation and comparing them with the existing epidural models. 34 Most recently, we have also undertaken a series of studies involving reciprocating translational movement of our spinal cord surrogate with the HSCMS mounted on it, to determine the ranges of motion available relative to the lead-loop's upper attachment point, before the rostral and caudal tips of the device begin to lift off the surrogate's surface.
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